Article History
Received: 27 February 2020
Revised: 1 June 2020
Accepted: 22 June 2020
First Online: 4 July 2020
Compliance with ethical standards
:
: Dr. Johnson is a consultant for The Rheumatology Education Group (TREG). Dr. Johnson owns stock in Johnson and Johnson Company and has provided paid consultancy to AbbVie and Novartis Pharmaceutical Companies. The other authors have disclosed no conflicts of interest. Authors have control of all primary data and agree to allow the journal to review it if requested.
: Einstein Institutional Board Review (IRB Number: 2015-5379).
: Forty-one patients provided informed consent.
: Forty-one patients provided consent.